Tesamorelin for Lipodystrophy When prescribed to treat lipodystrophy in HIV patients, the typical dose of tesamorelin is: One daily subcutaneous injection of tesamorelin 2mg of tesamorelin per dose Administered in the abdominal region Taken at night, at least 90 minutes after eating According to data from Phase III clinical trials involving HIV-infected study volunteers with lipodystrophy, this treatment produces significant reductions in visceral adipose tissue (VAT) fat without affecting adipose tissue (SAT) fat (on limbs or subcutaneously) when administered for 26 weeks
Implementing preventive strategies such as a balanced diet, lifestyle modifications, and seeking medical interventions can help mitigate hair loss concerns associated with GLP-1 use
209, 2014, pp
It acts by mimicking the effects of GLP-1, a hormone produced in the intestines that regulates blood sugar levels, promotes weight loss, and enhances overall metabolic function
Figure 2 3.1 Study characteristics and quality The nine publications evaluated included six clinical studies, two case series, and one survey
Wegovy prescription online processes can offer even more flexibility and cost-efficiency